Solgar Zinc Picolinate 22mg 100 Tablets
Solgar Zinc Picolinate 22mg 100 Tablets
Couldn't load pickup availability
{Solgar zinc picolinate 22 mg – Bottle of 100 tablets}
Solgar Zinc Picolinate 22 mg dietary supplement, available in a 100-unit bottle, is formulated to help maintain normal immune function and optimal nutrient metabolism. This product, distributed by the “Pharma+ France” parapharmacy of the Nobélis SASU group, meets the quality requirements specific to the Solgar brand.
Properties
- Zinc contributes to the normal functioning of the immune system.
- Zinc helps protect cells against oxidative stress.
- Zinc helps maintain normal skin, hair and nails.
- Zinc is involved in the normal metabolism of macronutrients and vitamin A.
Directions for use
According to the manufacturer's official instructions, take one tablet daily, preferably during a meal, with a large glass of water. Do not exceed the recommended daily dose. For adults only. Keep out of reach of young children. This dietary supplement is not a substitute for a varied, balanced diet and a healthy lifestyle.
Ingredients
Zinc picolinate, bulking agents (microcrystalline cellulose), anti-caking agents (vegetable magnesium stearate, silicon dioxide), hydroxypropyl methylcellulose, vegetable glycerin. For a complete list, see product packaging.
Legal notices:
This product is marketed by the parapharmacy “Pharma+ France” belonging to the company Groupe Nobélis SASU, a company registered with the Paris Trade and Companies Register under number 941 724 544. Groupe Nobélis SASU is not the manufacturer of this product, unless otherwise stated on the packaging or technical data sheet.
The information on this product sheet is provided for information purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the French Consumer Code.
They cannot in any case constitute a medical prescription nor replace the consultation of a qualified health professional. Any use of the product must comply with the instructions, the recommended dosage, and the precautions for use.
In accordance with Article L. 5122-15 of the Public Health Code, Groupe Nobélis declines all responsibility in the event of misuse, self-medication or non-compliance with official recommendations.
Photographs, descriptions, and technical information are non-contractual and are subject to change at any time. The user is encouraged to regularly check for updates or contact a healthcare professional for any treatment-related questions.
